Catalyst Pharmaceuticals
CPRX
#3688
Rank
C$5.42 B
Marketcap
C$44.33
Share price
0.00%
Change (1 day)
55.95%
Change (1 year)

Earnings for Catalyst Pharmaceuticals (CPRX)

Earnings in 2026 (TTM): C$0.40 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current earnings are C$0.59 Billion. In 2025 the company made an earning of C$0.39 Billion, an increase over its 2024 earnings that were of C$0.30 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalyst Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.40 B2.41%
2025 C$0.39 B31.1%
2024 C$0.30 B128.82%
2023 C$0.13 B-9.75%
2022 C$0.14 B98.83%
2021 C$74.14 M25.73%
2020 C$58.97 M25.38%
2019 C$47.03 M-198.25%
2018 -C$47.88 Million84.68%
2017 -C$25.93 Million1.88%
2016 -C$25.45 Million-10.68%
2015 -C$28.49 Million30.46%
2014 -C$21.84 Million27.6%
2013 -C$17.12 Million198.17%
2012 -C$5.74 Million-36.22%
2011 -C$9 Million59.52%
2010 -C$5.65 Million-44.68%
2009 -C$10.2 Million-31.45%
2008 -C$14.88 Million155.21%
2007 -C$5.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.57 B 8,663.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.91 B 3,472.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.45 B 2,644.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$34.44 M-91.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-C$0.39 Billion-191.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54 B 30.07%๐Ÿ‡บ๐Ÿ‡ธ USA